Early work focused on the serotonin reuptake inhibitors; however, the majority of the trials have been negative. There is a small body of evidence focused on pharmacotherapy for TTM. In future, larger trials are required to expand on the preliminary evidence available for N-acetylcysteine, olanzapine and dronabinol in recent trials.
Jon E. Grant, Tara S. Peris, Emily J. Ricketts, Christine Löchner, Dan Joseph Stein, Jan Štochl, Samuel R. Chamberlain, Jeremiah M. Scharf, Darin D. Dougherty, Douglas W. Woods, John Piacentini, Nancy J. Keuthen
Discussion(0)
No comments yet. Be the first to comment.